PharmiWeb4d
Clinical Trials Market Size and Share Report - 2025 to 2034
Clinical Trials Market OverviewThe Clinical Trials Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated between 2025 and 2034. As ...
Hyperthyroidism Global Clinical Trials Review 2024: Trial Status, Trial Phase, Sponsor Type and End Point Status
The "Hyperthyroidism - Global Clinical Trials Review, 2024" report has been added to ResearchAndMarkets.com's offering.This report provides top line data relating to the clinical trials on ...
Febrile Neutropenia Clinical Trials Review 2024, by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
The "Febrile Neutropenia - Global Clinical Trials Review, 2024" report has been added to ResearchAndMarkets.com's offering.The clinical trials report provides an overview of the Febrile Neutropenia ...
Vistagen advances Phase 3 SAD trials with 2025 data readout target
Vistagen Therapeutics' Q3 2025 earnings reveal progress on Phase 3 trials for social anxiety drug fasedienol, innovative therapies, and strong ...
INmune Bio, Inc.: INmune Bio Opens Phase II in High Dose Cohort of INKmune Trial in Prostate Cancer
Medical review of Phase 1 cohorts demonstrated no safety issuesData to be presented at the 10th Annual Innate Killer Summit, March 3-5 BOCA RATON, Fla, Feb. 12, 2025 (GLOBE NEWSWIRE) -- INmune Bio ...
Wave Life Sciences USA, Inc.: Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity
WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA - a genetically validated target that provides a new approach for healthy, sustainable weight loss (fat loss with muscle preservation) ...
Business Wire23d
Segal Trials Leads Phase 2 Schizophrenia Trial of LB-102 Toward Primary Endpoint
accounted for 18% of the total sample size in the Phase 2 study. A consistent top-enroller in acute schizophrenia clinical trials, Segal Trials contributed to the study sample size with a rate of ...
Pharmabiz1d
GenSight Biologics announces efficacy and safety results for Lumevoq gene therapy at the conclusion of the REFLECT phase III clinical study
GenSight Biologics announces efficacy and safety results for Lumevoq gene therapy at the conclusion of the REFLECT phase III clinical study: Paris Thursday, February 13, 2025, 17: ...
Clinical Trial Logistics Market Size, Navigating Growth Opportunities And Forecasted Outlook From 2024-2033
Emergen Research Logo The Clinical Trial Logistics Market is expected to grow from an estimated USD 3915.5 million in 2024 to USD 8504.0 mi ...
Hosted on MSN11d
Advanced Clinical chosen as CRO for Paradigm’s Phase III osteoarthritis trial
Paradigm Biopharmaceuticals has selected Advanced Clinical as the clinical research organisation (CRO) to support its pivotal ...
The Chronicle14d
Duke professor-led biotech company raises $175 million to advance epigenome editing therapy clinical trials
Currently, the company is in its first phase of clinical trials. Gersbach emphasized that once the optimal dosage is determined in the initial phase, the trial will progress to its second phase ...
Scoop27d
Marae-based Study Into Psychoactive Mushroom For Treating Methamphetamine Addiction Completes First Phase Of Trials
A clinical study using mushrooms containing the psychoactive psilocybin to treat methamphetamine addiction has just completed its first phase of trials. Over the past month the first cohort of ...